Abiopharma

New Form 4 - NATIONAL RESEARCH CORP Filed: 2025-05-09 AccNo: 0001008886-25-000114 Size: 5 KB

New Form 4 - Royalty Pharma plc Filed: 2025-05-09 AccNo: 0001802768-25-000031 Size: 5 KB

New Form 4 - NATIONAL RESEARCH CORP Filed: 2025-05-09 AccNo: 0001008886-25-000113 Size: 5 KB

New Form 4 - NATIONAL RESEARCH CORP Filed: 2025-05-09 AccNo: 0001008886-25-000112 Size: 5 KB

New Form 4 - CUMBERLAND PHARMACEUTICALS INC Filed: 2025-05-09 AccNo: 0001628280-25-024355 Size: 34 KB

New Form 4 - CUMBERLAND PHARMACEUTICALS INC Filed: 2025-05-09 AccNo: 0001628280-25-024353 Size: 34 KB

New Form 4 - INTERNATIONAL FLAVORS & FRAGRANCES INC Filed: 2025-05-09 AccNo: 0001225208-25-004916 Size: 8 KB

New Form 4 - CUMBERLAND PHARMACEUTICALS INC Filed: 2025-05-09 AccNo: 0001628280-25-024349 Size: 35 KB

UTHR: Notification

New Form 4 - AGILENT TECHNOLOGIES, INC. Filed: 2025-05-09 AccNo: 0001127602-25-013874 Size: 5 KB

New Form 4 - CUMBERLAND PHARMACEUTICALS INC Filed: 2025-05-09 AccNo: 0001628280-25-024346 Size: 35 KB

New Form 10-Q - CUMBERLAND PHARMACEUTICALS INC Filed: 2025-05-09 AccNo: 0001628280-25-024342 Size: 4 MB

HealthEquity Announces First Quarter Earnings Release Date Presentations at Investor Conferences

New Form 4 - Kiniksa Pharmaceuticals International, plc Filed: 2025-05-09 AccNo: 0001415889-25-012541 Size: 8 KB

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting